Literature DB >> 18839473

Reference ranges and diagnostic thresholds of laboratory markers of cardiac damage and dysfunction in a population of apparently healthy black Africans.

Martina Montagnana1, Giuseppe Lippi, Gian Luca Salvagno, Gian Cesare Guidi.   

Abstract

BACKGROUND: Due to the increasing migration flows mostly concerning Western countries, the problem of reference ranges and cut-off values is a living matter. In particular, the influence of ethnic origin on traditional and novel biochemical markers of cardiac damage, including cardiac troponin T (cTnT), ischemia modified albumin (IMA) and N-terminal prohormone brain natriuretic peptide (NT-proBNP), has not been investigated, to the best of our knowledge.
METHODS: CTnT, NT-proBNP and IMA were assayed by a Modular System in 34 apparently healthy black Africans originating mainly from Central Africa and in 34 apparently healthy white, non-immigrant Italians, matched for age and sex.
RESULTS: All the subjects investigated displayed cTnT values < 0.01 ng/mL. Black Africans displayed significantly increased concentrations of serum IMA (107 vs. 92 kU/L, p < 0.0001), but not of NT-proBNP (4.9 vs. 3.8 pmol/L, p = 0.4), as compared to the white, nonimmigrant Italians.
CONCLUSIONS: The results of our investigation indicate that the reference ranges and the thresholds values of IMA, but not those of cTnT and NT-proBNP, may be different according to the ethnic origin of the population. Therefore, although the current decisional thresholds of both cTnT and NT-proBNP may be appropriate for diagnosing cardiac damage and dysfunction in the black African population, that of IMA may require a revision toward higher values.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839473     DOI: 10.1515/cclm.2008.130

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

1.  Racial Differences in Natriuretic Peptide Levels: The Dallas Heart Study.

Authors:  Deepak K Gupta; James A de Lemos; Colby R Ayers; Jarett D Berry; Thomas J Wang
Journal:  JACC Heart Fail       Date:  2015-06-10       Impact factor: 12.035

Review 2.  A Systematic Review and Meta-Analysis of Serum Concentrations of Ischaemia-Modified Albumin in Acute Ischaemic Stroke, Intracerebral Haemorrhage, and Subarachnoid Haemorrhage.

Authors:  Arduino A Mangoni; Angelo Zinellu
Journal:  Biomolecules       Date:  2022-04-29

3.  Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lori B Daniels; Paul Clopton; Christopher R deFilippi; Otto A Sanchez; Hossein Bahrami; Joao A C Lima; Russell P Tracy; David Siscovick; Alain G Bertoni; Philip Greenland; Mary Cushman; Alan S Maisel; Michael H Criqui
Journal:  Am Heart J       Date:  2015-09-28       Impact factor: 4.749

4.  Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Navkaranbir S Bajaj; Orlando M Gutiérrez; Garima Arora; Suzanne E Judd; Nirav Patel; Aleena Bennett; Sumanth D Prabhu; George Howard; Virginia J Howard; Mary Cushman; Pankaj Arora
Journal:  JAMA Cardiol       Date:  2018-01-01       Impact factor: 14.676

5.  Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study.

Authors:  Deepak K Gupta; Brian Claggett; Quinn Wells; Susan Cheng; Man Li; Nisa Maruthur; Elizabeth Selvin; Josef Coresh; Suma Konety; Kenneth R Butler; Thomas Mosley; Eric Boerwinkle; Ron Hoogeveen; Christie M Ballantyne; Scott D Solomon
Journal:  J Am Heart Assoc       Date:  2015-05-21       Impact factor: 5.501

Review 6.  Serum Concentrations of Ischaemia-Modified Albumin in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Arduino A Mangoni; Angelo Zinellu
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

7.  Racial/ethnic differences in circulating natriuretic peptide levels: The Diabetes Prevention Program.

Authors:  Deepak K Gupta; Geoffrey A Walford; Yong Ma; Petr Jarolim; Thomas J Wang
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.